The recent use of advanced proteomic approaches is clearly challenging the understanding of sperm biology. The group led by Dr. Rafael Oliva, within the IDIBAPS Molecular genetics Team, has provided in the recent years a series of original works about the composition and complexity of sperm. With a new review, published recently at Human Reproduction Update with Alexandra Amaral as its firs author, the team discusses various human sperm proteomic studies to create a compiled list of all the sperm proteins described to date and to re-assess the potential functional implications. The group also leads the Reprotrain project, funded by the European Commission.
Archive for the ‘Hospital Clínic’ Category
Treatment of atrial fibrillation through ablation is more effective than antiarrhythmic drug treatment
A recent study, conducted in 8 hospitals in Spain and led from the Hospital Clínic – IDIBAPS, has randomly compared catheter ablation vs. antiarrhythmic drug in the treatment of persistent atrial fibrillation. The SARA Study (Study of Ablation vs Antiarrhythmic Drugs in Persistent Atrial Fibrillation) has been published as Fast Track in the journal European Heart Journal. After one year of monitoring, the study concludes that treatment with ablation is more effective than antiarrhythmic drugs in preventing relapse of the arrhythmia. In the group treated with ablation the 70% of patients did not present any long lasting relapse of the arrhythmia, whereas among patients treated with antiarrhythmic drugs only 43 % were free of relapse during the follow-up. Dr. Lluis Mont, from the Cardiology Department at Hospital Clínic de Barcelona and IDIBAPS investigator at the Arrhythmias, resynchronization and cardiac imaging Team, is the first author of the study, while Dr. Josep Brugada, from the same service and research team and also Medical Director of the Hospital Clínic, is the last one.
A study led by Inherited Metabolic Diseases IDIBAPS team, directed by Dr. Antònia Ribes from Hospital Clínic of Barcelona, identified in one patient the LIPT1 gene as a new element involved in the metabolism of lipoic acid. Thanks to these results, now published in the journal Human Molecular Genetics, Frederic Tort received the first prize for the best oral presentation at the 12th International Congress of Inborn Errors of Metabolism (ICIEM), held in September in Barcelona.
Gender-based violence, on addition to a risk on physical integrity creates a state of chronic stress and alert which affect the quality of life of those suffering it. It is mandatory to work towards the eradication of this form of violence using all possible scientific and legal strategies. An interdisciplinary group of researchers, physicians, psychologists and lawyers, will participate tomorrow , Friday December 13th from 16h at the CEK Building’s Esteve Auditorium (C / Rosselló 149-153; 08036, Barcelona), a conference to discuss this problem from different perspectives. The initiative has been promoted by Dr. Maria Victoria Sanchez-Vives, ICREA researcher on Neurosciences at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and associate professor at the School of Psychology at the University of Barcelona (UB), together with Marc Cerón, from the Department of Justice of the Catalan Government (Generalitat de Catalunya).
The Catalan Government and the Institució Catalana de Recerca i Estudis Avançats (ICREA), presented the list of 24 researchers from the Catalan research system awarded with ICREA Academia distinctions. Among them is Dr. Elías Campo, head of the IDIBAPS Human and experimental functional oncomorphology, Director of Research at Hospital Clínic of Barcelona and at the Fundació Clinic, who has also been recently announced as the new Catalan National Research Award winner. The ICREA Academia awards, which celebrate its V edition, recognize the research work of teaching staff in a Catalan public university while, at the same time, helps to retain research talent within the Catalan university system. The award, which includes a 50,000 euros grant, involves a preferent dedication to research during 5 years.
information via www.govern.cat